Blue Chip Group, Inc – FDA 483, Feb 13, 2019
The FDA issued a Form 483 to Blue Chip Group, Inc. in Salt Lake City, UT, following an inspection that identified significant deficiencies in sanitation principles, allergen control, and personnel practices. Observations included inadequate cleaning of scoops used for allergen and non-allergen ingredients, improper handling of spilled allergen-containing materials, and poor employee hygiene practices during ready-to-eat product manufacturing. These issues indicate a risk of product contamination and allergen cross-contact.
ID · fe3555f3-06d6-4d60-8881-c3b613e6327b
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.